APA (7th ed.) Citation

Möbus, V., Lück, H., Ladda, E., Klare, P., Engels, K., Schmidt, M., . . . Loibl, S. (2024). GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer. npj Breast cancer, 10(1), . https://doi.org/10.1038/s41523-024-00675-x

Chicago Style (17th ed.) Citation

Möbus, Volker, et al. "GAIN2 Trial Overall Survival with Intense Versus Tailored Dose Dense Chemotherapy in Early Breast Cancer." Npj Breast Cancer 10, no. 1 (2024). https://doi.org/10.1038/s41523-024-00675-x.

MLA (9th ed.) Citation

Möbus, Volker, et al. "GAIN2 Trial Overall Survival with Intense Versus Tailored Dose Dense Chemotherapy in Early Breast Cancer." Npj Breast Cancer, vol. 10, no. 1, 2024, https://doi.org/10.1038/s41523-024-00675-x.